Global Peripheral Artery Disease Market to Progress at a CAGR of 3.49% by 2028 Analyzed by DelveInsight | Medtronic, Koninklijke Philips N.V., B.Braun SE, Boston Scientific Corporation, BD, Terumo Corporation, Biotronik, Cordis, Abbott, AngioDynamics, Car

As per DelveInsight's assessment, the Peripheral Artery Disease Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Peripheral Artery Disease have been used, which is expected to drive the demand for Peripheral Artery Disease in the upcoming years.

DelveInsight's "Peripheral Artery Disease Market" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Peripheral Artery Disease companies actively working in the market.
Request a Free Sample for "Peripheral Artery Disease Market":
https://www.delveinsight.com/report-store/peripheral-artery-disease-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Peripheral Artery Disease
Peripheral Artery Disease (PAD) is a circulatory condition that occurs when the arteries, primarily those supplying blood to the legs and feet, become narrowed or blocked due to atherosclerosis. Atherosclerosis is a buildup of plaque made up of cholesterol, fatty substances, calcium, and other materials on the artery walls.

Peripheral Artery Disease Market Insights
In 2022, North America is projected to hold the most substantial portion of the peripheral artery disease and stenosis treatment devices market. This dominance is attributed to crucial growth influencers such as the escalating prevalence of peripheral artery disease and its associated risk factors, a growing elderly population, and the presence of prominent market participants. These factors collectively are anticipated to drive market growth in North America in the forthcoming years.
DelveInsight Peripheral Artery Disease Market Size Analysis: The Global Peripheral Artery Disease market size is and anticipated to grow rapidly by 2028 with a significant CAGR during the forecasted period (2023-2028)
To know more about why North America is leading the market growth in the Peripheral Artery Disease market, get a snapshot of the report Peripheral Artery Disease Market Trends
https://www.delveinsight.com/sample-request/peripheral-artery-disease-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Peripheral Artery Disease Market Report
• In June 2023, Surmodics, Inc., A leading provider of medical equipment and diagnostic technologies in the healthcare industry revealed that it received approval from the U.S. Food and Drug Administration (FDA) for its SurVeil™ drug-coated balloon (DCB). The DCB is specifically created for percutaneous transluminal angioplasty after appropriate vessel preparation.
• In October 2023, Boston Scientific Corporation reported positive results from the critical AGENT IDE clinical trial, specifically regarding the 12-month evaluation of the effectiveness of the AGENT™ Drug-Coated Balloon (DCB). The trial's objective was to evaluate how safe and efficient it is to use a DCB in treating coronary in-stent restenosis (ISR).
• In November 2022, Genesis MedTech Group announced that the FDA has granted approval for the Chocolate Touch drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter. This approval specifically allows its use in addressing peripheral artery disease in the superficial femoral artery and the popliteal artery for affected patients.
• Thus, owing to such developments in the market, rapid growth will be observed in the Peripheral Artery Disease market during the forecast period
To read more about the latest highlights related to Peripheral Artery Disease, get a snapshot of the key highlights entailed in the Peripheral Artery Disease
https://www.delveinsight.com/sample-request/peripheral-artery-disease-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Key Players in the Peripheral Artery Disease Market
Some of the key Peripheral Artery Disease companies operating in the market include- Medtronic, Koninklijke Philips N.V., B.Braun SE, Boston Scientific Corporation, BD, Terumo Corporation, Biotronik, Cordis, Abbott, AngioDynamics, Cardiovascular Systems, Inc., Bluesail Medical Co., Ltd., Contego Medical, Inc., Argon Medical, Rex Medical, Merck & Co., Inc., Sanofi, Johnson and Johnson Services, Inc., Otivio, Reflow Medical Inc., and others.

Peripheral Artery Disease Market Dynamics:
According to the Global Burden of Disease 2019 report, there were approximately 56.4 million prevalent cases of Peripheral Artery Disease (PAD) among individuals aged 40 to 70 globally in 2019. The Canadian Journal of Cardiology article indicated a global PAD prevalence of 5.6%, with higher rates in high-income countries compared to low-income nations. Additionally, a 2022 research study revealed that 113,443,017 individuals lived with PAD, with 10,504,092 new cases reported in 2019.

Furthermore, the same study highlighted that 75% of acute myocardial infarctions result from plaque rupture, with the highest incidence observed in men over 45 years old. Conversely, in women, the incidence tends to rise after the age of 50.

Yet, the elevated expenses associated with diverse devices and the occurrence of unfavorable events linked to different treatments could potentially impede the expansion of the total market for peripheral artery disease and stenosis treatment devices throughout the projected period.
Scope of the Peripheral Artery Disease Market Report
• Coverage: Global
• Study Period: 2020-2028
• Peripheral Artery Disease Market Segmentation By Product Type: Angioplasty And Drug-Coated Balloons, Angioplasty Stents, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Guidewires
• Peripheral Artery Disease Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, And Specialty Clinics
• Peripheral Artery Disease Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Peripheral Artery Disease Companies: Medtronic, Koninklijke Philips N.V., B.Braun SE, Boston Scientific Corporation, BD, Terumo Corporation, Biotronik, Cordis, Abbott, AngioDynamics, Cardiovascular Systems, Inc., Bluesail Medical Co., Ltd., Contego Medical, Inc., Argon Medical, Rex Medical, Merck & Co., Inc., Sanofi, Johnson and Johnson Services, Inc., Otivio, Reflow Medical Inc., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the Peripheral Artery Disease market are set to emerge as the trendsetter explore @ Peripheral Artery Disease
https://www.delveinsight.com/sample-request/peripheral-artery-disease-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Peripheral Artery Disease Market Report Introduction
2 Peripheral Artery Disease Market Executive summary
3 Regulatory and Patent Analysis
4 Peripheral Artery Disease Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Peripheral Artery Disease Market
7 Peripheral Artery Disease Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Project Approach
11. About DelveInsight

Interested in knowing how the Peripheral Artery Disease market will grow by 2027? Click to get a snapshot of the Peripheral Artery Disease Market Analysis
https://www.delveinsight.com/sample-request/peripheral-artery-disease-market-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports
Cancer Immunotherapy Market
https://www.delveinsight.com/report-store/cancer-immunotherapy-market
Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Immunomodulators, Cancer Vaccines, Checkpoint Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By End-User (Hospitals And Clinics, Specialty Centers, And Others), and by geography is expected to rise at a significant CAGR forecast till 2027 owing to the accelerating prevalence of cancers and surging healthcare expenditure across the globe

Companion Diagnostics Market
https://www.delveinsight.com/report-store/companion-diagnostics-market
Companion Diagnostics Market By Type (Product [Assays, Kits & Reagents And Instruments], and Services), Technology (Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Others), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, and Others), End-User (Hospitals, Diagnostic Labs, and Others), and Geography is expected to grow at a noteworthy CAGR till 2028 owing to the increase in the cancer burden across the globe and the growing focus on personalized medicines.

Telemedicine Service Market
https://www.delveinsight.com/report-store/telemedicine-service-market
Telemedicine Service Market By Service Type (Tele Consulting And Tele Monitoring), By Application (Telepathology, Telecardiology, Teleradiology, Teledermatology, Telepsychiatry, Other Services), By End-User (Healthcare Facilities And Homecare), by geography, is projected to grow at a significant CAGR forecast till 2028 owing to the sudden outbreak of covid-19 pandemic and shifting focus for reducing the burden of healthcare cost.

DNA Sequencing Market
https://www.delveinsight.com/report-store/dna-sequencing-market
DNA Sequencing Market By Products & Services (Instruments, Consumbales, And Services), By Technology (Sanger Sequencing, Next-Generation Sequencing, And Long-Read Sequencing), By Application (Disease Diagnosis, Precision Medicine, And Research), By End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical Companies, And Academic Institutes), and by geography is estimated to grow at an appreciable CAGR forecast till 2028 owing to rising prevalence of genetic disorders and growing popularity of precision medicine.

Next Generation Sequencing Market
https://www.delveinsight.com/report-store/next-generation-sequencing-market
Next-Generation Sequencing Market By Product Type (Instruments, Reagents & Consumables And Services), By Sequencing Type (Whole-Genome Sequencing, Whole-Exome Sequencing, Rna Sequencing, Targeted Sequencing, De-Novo Sequencing, Others), By Application (Diagnostic, Drug Discovery, Agriculture & Animal Research, Others), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Academic & Research Institute), by geography, is expected to grow at a significant CAGR forecast till 2028 owing to the rising application of next-generation sequencing (NGS) technology in clinical diagnosis and advancement in NGS platforms.

Active Pharmaceutical Ingredient Market
https://www.delveinsight.com/report-store/active-pharmaceutical-ingredient-api-market
Active Pharmaceutical Ingredient (API) Market By Type (Innovative And Generic), By Manufacturer Type (Captive And Merchant), By Synthesis Type (Synthetic And Biotech), By Application (Oncology, Cardiology, Pulmonology, Neurology, Orthopedic, Opthalmology, And Others), by geography is estimated to register growth at remarkable CAGR forecast till 2027 owing to rising prevalence of various diseases such as diabetes and growing focus on drug development

Clinical Diagnostics Market
https://www.delveinsight.com/report-store/clinical-diagnostics-market
Clinical Diagnostics Market By Type (Products [Instruments, Kits & Reagents], Services), Test (Complete Blood Count (CBC), Metabolic Panel, Lipid Panel, Renal Panel, Liver Panel, Infectious Disease Testing, and Others), End-User (Hospitals, Pathology Labs, and Others), and Geography, is expected to expand at a significant CAGR till 2028 owing to the growing cases of various chronic diseases & infectious diseases across the globe and rise in the integration of technological advancements in the product portfolio.

Contact Us
Gaurav Bora
info@delveinsight.com
+1(919)321-6187
https://www.delveinsight.com/medical-devices

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.